On 5/15/24, Inovio Pharmaceuticals Inc (NASDAQ: INO) stock enjoyed a major increase of 14.4%, closing at $13.07. Moreover, this advance was accompanied by unusually high trading volume at 166% of normal. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 17.2% during the last week.
Current PriceTarget Research Rating
INO’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to continue to be Value Creation neutral.
Inovio Pharmaceuticals has a current Value Trend Rating of C (Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Inovio Pharmaceuticals has a very low Appreciation Score of 8 but a very high Power Rating of 90, and the Neutral Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment